The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
Crossref DOI link: https://doi.org/10.1007/s40262-015-0326-7
Published Online: 2015-09-14
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Echizen, Hirotoshi
Text and Data Mining valid from 2015-09-14